Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 76

Sort by

Sort Order Select

Journal Articles

Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State

Bethel Tesfai Embaie, Hirak Sarkar, Adele M. Alchahin, Jörg Otte, Thale Kristin Olsen, Conny Tümmler, Polina Kameneva, Artem V. Artemov, Natalia Akkuratova, Igor Adameyko, Jan-Bernd Stukenborg, Malin Wickström, Per Kogner, John Inge Johnsen, Shenglin Mei, Peter V. Kharchenko, Ninib Baryawno

Cancer Res (2025) 85 (6): 1015–1034.

https://doi.org/10.1158/0008-5472.CAN-24-1507

Published: 14 March 2025

View articletitled, Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State

Includes: Supplementary data

Journal Articles

Abstract B060: Clonal composition of αβ and γδ T cells in primary human neuroblastoma tumors – Is every child unique?

Bronte Manouk Verhoeven, Kewei Ye, Jakob Stenman, Per Kogner, John Inge Johnsen, Oscar Bedoya Reina, Taras Kreslavskiy, Ninib Baryawno

Cancer Res (2024) 84 (17_Supplement): B060.

https://doi.org/10.1158/1538-7445.PEDIATRIC24-B060

Published: 05 September 2024

View articletitled, Abstract B060: Clonal composition of αβ and γδ T cells in primary human neuroblastoma tumors – Is every child unique?

Journal Articles

Abstract 6378: Systems-level immunomonitoring in children with solid tumors

Cancer Res (2024) 84 (6_Supplement): 6378.

https://doi.org/10.1158/1538-7445.AM2024-6378

Published: 22 March 2024

View articletitled, Abstract 6378: Systems-level immunomonitoring in children with solid tumors

Journal Articles

Abstract 6215: The immune cell atlas of human neuroblastoma

Bronte Manouk Verhoeven, Shenglin Mei, Thale K. Olsen, Karin K. Gustafsson, Anders Valind, Axel Lindström, David G. Nord, Shahrzad S. Fard, Catharina Hagerling, Peter V. Kharchenko, Per Kogner, John I. Johnsen, Ninib Baryawno

Cancer Res (2022) 82 (12_Supplement): 6215.

https://doi.org/10.1158/1538-7445.AM2022-6215

Published: 15 June 2022

View articletitled, Abstract 6215: The immune cell atlas of human neuroblastoma

Journal Articles

Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma

Sanhita Mitra, Somsundar Veppil Muralidharan, Mirco Di Marco, Prasanna Kumar Juvvuna, Subazini Thankaswamy Kosalai, Silke Reischl, Daniel Jachimowicz, Santhilal Subhash, Ivan Raimondi, Leo Kurian, Maite Huarte, Per Kogner, Matthias Fischer, John Inge Johnsen, Tanmoy Mondal, Chandrasekhar Kanduri

Cancer Res (2021) 81 (6): 1457–1471.

https://doi.org/10.1158/0008-5472.CAN-19-3499

Published: 15 March 2021

View articletitled, Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma

Includes: Supplementary data

Journal Articles

Abstract 1692: Genomic changes in relapsed neuroblastoma

Susanne Fransson, Angela Martinez Monleon, Anna Djos, Susanne Reinsbach, Rose-Marie Sjoberg, Per Sikora, Per Kogner, Tommy Martinsson

Cancer Res (2019) 79 (13_Supplement): 1692.

https://doi.org/10.1158/1538-7445.AM2019-1692

Published: 01 July 2019

View articletitled, Abstract 1692: Genomic changes in relapsed neuroblastoma

Journal Articles

Abstract 5092: Establishment of an induction protocol for medulloblastoma during prenatal stages of a floxed-cre inducible model

Gabriel Gallo-Oller, Ani Azatyan, Ninib Baryawno, Per Kogner, John Inge Johnsen

Cancer Res (2018) 78 (13_Supplement): 5092.

https://doi.org/10.1158/1538-7445.AM2018-5092

Published: 01 July 2018

View articletitled, Abstract 5092: Establishment of an induction protocol for medulloblastoma during prenatal stages of a floxed-cre inducible model

Journal Articles

Abstract 3185: Whole genome sequencing for precision medicine in high-risk neuroblastoma patients: Translation from research to clinical practice in Sweden

Susanne M. Fransson, Angela Martinez-Monleon, Susanne Reinsbach, Per Sikora, Rosa-Marie Sjoberg, Per Kogner, Tommy Martinsson

Cancer Res (2018) 78 (13_Supplement): 3185.

https://doi.org/10.1158/1538-7445.AM2018-3185

Published: 01 July 2018

View articletitled, Abstract 3185: Whole genome sequencing for precision medicine in high-risk neuroblastoma patients: Translation from research to clinical practice in Sweden

Journal Articles

Abstract 2246: Identification of mutational signatures in high-risk neuroblastoma patients

Susanne E. Reinsbach, Malin Larsson, Angela Martinez-Monleon, Rose-Marie Sjöberg, Niloufar Javanmardi, Anna Djos, Per Kogner, Susanne Fransson, Erik Larsson Lekholm, Tommy Martinsson

Cancer Res (2018) 78 (13_Supplement): 2246.

https://doi.org/10.1158/1538-7445.AM2018-2246

Published: 01 July 2018

View articletitled, Abstract 2246: Identification of mutational signatures in high-risk neuroblastoma patients

Journal Articles

Abstract 4145: Characterization of the ODZ receptor family in neuroblastoma

Teodora Andonova, Per Kogner, John Inge Johnsen, Malin Wickström

Cancer Res (2018) 78 (13_Supplement): 4145.

https://doi.org/10.1158/1538-7445.AM2018-4145

Published: 01 July 2018

View articletitled, Abstract 4145: Characterization of the ODZ receptor family in neuroblastoma

Journal Articles

Abstract B40: A novel activating I1171T ALK mutation in neuroblastoma responds better to ceritinib compare to the first generation inhibitor crizotinib

Joachim T. Siaw, Jikui Guan, Tommy Martinsson, Magnus Hansson, Per Kogner, Ruth Palmer

Cancer Res (2017) 77 (22_Supplement): B40.

https://doi.org/10.1158/1538-7445.NEWFRONT17-B40

Published: 14 November 2017

View articletitled, Abstract B40: A novel activating I1171T ALK mutation in neuroblastoma responds better to ceritinib compare to the first generation inhibitor crizotinib

Journal Articles

Abstract 5832: Rho-associated kinase is a therapeutic target in neuroblastoma

Cecilia H. Dyberg, Susanne Fransson, Teodora Andonova, Baldur Sveinbjörnsson, Jessika Lännerholm-Palm, David Forsberg, Eric Herlenius, Tommy Martinsson, Per Kogner, John Inge Johnsen, Malin Wickström

Cancer Res (2017) 77 (13_Supplement): 5832.

https://doi.org/10.1158/1538-7445.AM2017-5832

Published: 01 July 2017

View articletitled, Abstract 5832: Rho-associated kinase is a therapeutic target in neuroblastoma

Journal Articles

Abstract 4867: Exome- and whole genome sequencing for clinical evaluation and precision medicine in neuroblastoma

Angela Martinez Monleon, Susanne Reinsbach, Niloufar Javanmardi, Anna Djos, Rose-Marie Sjoberg, Per Kogner, Tommy Martinsson, Susanne Fransson

Cancer Res (2017) 77 (13_Supplement): 4867.

https://doi.org/10.1158/1538-7445.AM2017-4867

Published: 01 July 2017

View articletitled, Abstract 4867: Exome- and whole genome sequencing for clinical evaluation and precision medicine in neuroblastoma

Journal Articles

Abstract 687: Targeting tumor-promoting neuroblastoma microenvironment: inhibiton of tumor development and progression by targeting mPGES-1 expressed by cancer associated fibroblasts

Anna Kock, Karin Larsson, Nina Eissler, Filip Bergqvist, Joan Rauf, Marina Korotkova, John-Inge Johnsen, Per-Johan Jakobsson, Per Kogner

Cancer Res (2017) 77 (13_Supplement): 687.

https://doi.org/10.1158/1538-7445.AM2017-687

Published: 01 July 2017

View articletitled, Abstract 687: Targeting tumor-promoting neuroblastoma microenvironment: inhibiton of tumor development and progression by targeting mPGES-1 expressed by cancer associated fibroblasts

Journal Articles

Abstract 1945: PPM1D/Wip1, promising new target in childhood cancers neuroblastoma and medulloblastoma

Jelena Milosevic, Nina Eissler, Diana Treis, Malin Wicktröm, Susanne Fransson, Baldur Sveinbjornsson, Ninib Baryawno, Subazini Kosalai, Chandrasekhar Kanduri, Kazuyasu Sakaguchi, Tommy Martinsson, John Inge Johnsen, Per Kogner

Cancer Res (2017) 77 (13_Supplement): 1945.

https://doi.org/10.1158/1538-7445.AM2017-1945

Published: 01 July 2017

View articletitled, Abstract 1945: PPM1D/Wip1, promising new target in childhood cancers neuroblastoma and medulloblastoma

Journal Articles

Abstract 4876: Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment

Susanne M. Fransson, Niloufar Javanmardi, Rose-Marie Sjoberg, Per Kogner, Tommy Martinsson

Cancer Res (2017) 77 (13_Supplement): 4876.

https://doi.org/10.1158/1538-7445.AM2017-4876

Published: 01 July 2017

View articletitled, Abstract 4876: Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment

Journal Articles

Abstract 761: Specific inhibition of prostaglandin E2 production in medulloblastoma

Filip Bergqvist, Linda Ljungblad, Malin Wickström, Karin Larsson, Anna Kock, Marina Korotkova, John Inge Johnsen, Per Kogner, Per-Johan Jakobsson

Cancer Res (2016) 76 (14_Supplement): 761.

https://doi.org/10.1158/1538-7445.AM2016-761

Published: 15 July 2016

View articletitled, Abstract 761: Specific inhibition of prostaglandin E2 production in medulloblastoma

Journal Articles

Abstract 2454: Omega-3 fatty acids DHA and EPA decrease oncogenic PGE2 in medulloblastoma in vitro and in vivo

Linda Ljungblad, Filip Bergqvist, Teodora Andonova, Per-Johan Jakobsson, John Inge Johnsen, Per Kogner, Malin Wickström

Cancer Res (2016) 76 (14_Supplement): 2454.

https://doi.org/10.1158/1538-7445.AM2016-2454

Published: 15 July 2016

View articletitled, Abstract 2454: Omega-3 fatty acids DHA and EPA decrease oncogenic PGE2 in medulloblastoma in vitro and in vivo

Journal Articles

Abstract 2430: Neuroblastoma: Telomere elongation is responsible for aggressive behavior

Niloufar Javanmardi, Susanne Fransson, Rose-Marie Sjöberg, Anna Djos, Per Kogner, Tommy Martinsson

Cancer Res (2016) 76 (14_Supplement): 2430.

https://doi.org/10.1158/1538-7445.AM2016-2430

Published: 15 July 2016

View articletitled, Abstract 2430: Neuroblastoma: Telomere elongation is responsible for aggressive behavior

Journal Articles

Abstract 2435: Amplification of CDK4 and MDM2 is associated with atypical clinical features in high risk neuroblastoma patients

Susanne M. Fransson, Hanna Kryh, Niloufar Javanmardi, Inge M. Ambros, Ana P. Berbegall, Ingrid Ora, Rosa Noguera, Jurate Asmundsson, Bengt Sandstedt, Peter F. Ambros, Per Kogner, Tommy Martinsson

Cancer Res (2016) 76 (14_Supplement): 2435.

https://doi.org/10.1158/1538-7445.AM2016-2435

Published: 15 July 2016

View articletitled, Abstract 2435: Amplification of CDK4 and MDM2 is associated with atypical clinical features in high risk neuroblastoma patients

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State

Abstract B060: Clonal composition of αβ and γδ T cells in primary human neuroblastoma tumors – Is every child unique?

Abstract 6378: Systems-level immunomonitoring in children with solid tumors

Abstract 6215: The immune cell atlas of human neuroblastoma

Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma

Abstract 1692: Genomic changes in relapsed neuroblastoma

Abstract 5092: Establishment of an induction protocol for medulloblastoma during prenatal stages of a floxed-cre inducible model

Abstract 3185: Whole genome sequencing for precision medicine in high-risk neuroblastoma patients: Translation from research to clinical practice in Sweden

Abstract 2246: Identification of mutational signatures in high-risk neuroblastoma patients

Abstract 4145: Characterization of the ODZ receptor family in neuroblastoma

Abstract B40: A novel activating I1171T ALK mutation in neuroblastoma responds better to ceritinib compare to the first generation inhibitor crizotinib

Abstract 5832: Rho-associated kinase is a therapeutic target in neuroblastoma

Abstract 4867: Exome- and whole genome sequencing for clinical evaluation and precision medicine in neuroblastoma

Abstract 687: Targeting tumor-promoting neuroblastoma microenvironment: inhibiton of tumor development and progression by targeting mPGES-1 expressed by cancer associated fibroblasts

Abstract 1945: PPM1D/Wip1, promising new target in childhood cancers neuroblastoma and medulloblastoma

Abstract 4876: Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment

Abstract 761: Specific inhibition of prostaglandin E2 production in medulloblastoma

Abstract 2454: Omega-3 fatty acids DHA and EPA decrease oncogenic PGE2 in medulloblastoma in vitro and in vivo

Abstract 2430: Neuroblastoma: Telomere elongation is responsible for aggressive behavior

Abstract 2435: Amplification of CDK4 and MDM2 is associated with atypical clinical features in high risk neuroblastoma patients

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only